| RA | Control | T test | P |
---|---|---|---|---|
Age (years) mean ± SD | 45.5 ± 9.8 | 43.4 ± 7.7 | 0.7 | 0.5 |
Sex (male) n (%) | 8 (36) | 9 (40.9) | 2.2 | 0.6 |
Age of onset (years) (mean ± SD) | 25.5 ± 4.6 | NA | NA | NA |
Duration (years) (mean ± SD) | 8.2±2.7 | NA | NA | NA |
Chest expansion (mean ± SD) | 2 ± 1.6 | 3 ± 0.6 | 0.7 | 0.8 |
Seropositive RF | 15 (68.2%) | 0 (0%) | 3 | 0.007* |
Anti-ccp2 | 17(68.2%) | 0(0%) | 2.2 | 0.02* |
DAS28-ESR (mean ± SD) | 4.9 ± 0.7 | NA | NA | NA |
mHAQ (mean ± SD) | 5 ± 1.09 | NA | NA | NA |
Medications n(% | ||||
 Biological DMARDs | 11 (50) | NA | NA | NA |
 Conventional DMARDs | 5 (22.7) |  |  |  |